Lunai Bioworks Inc. (LNAI) Form 10-K — Oct 13, 2026
Lunai Bioworks (Nasdaq: LNAI) filed its fiscal 2026 10-K with substantial doubt about its ability to continue as a going concern. The company reported cash of $1,713,653 as of June 30, 2026 and stated it had less than one month of available cash resources as of October 13, 2026, against an accumulated deficit of $514 million. The company reported a fiscal 2026 net loss of $3,562,479 (vs. $178,007,489 in fiscal 2025) and only $51,992 of service revenue from a single customer.
Key figures
- Total Debt
- 0
- Total Assets
- 0
- Cash Position
- 1713653
- Shares Outstanding
- 5034452
- Net loss fy2025
- 178007489
- Full time employees
- 12
- Accumulated deficit fy2025
- 510462570
- Accumulated deficit fy2026
- 514025049
- Fiscal2026 service revenue
- 51992
- Non affiliate market value dec2025
- 21311198
AI analysis
Red flags8 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.